Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1921 | 2016 |
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic H Hampel, SE O’Bryant, JL Molinuevo, H Zetterberg, CL Masters, S Lista, ... Nature Reviews Neurology 14 (11), 639-652, 2018 | 629 | 2018 |
The β-secretase BACE1 in Alzheimer’s disease H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ... Biological psychiatry 89 (8), 745-756, 2021 | 541 | 2021 |
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 367 | 2019 |
Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic SE O'Bryant, MM Mielke, RA Rissman, S Lista, H Vanderstichele, ... Alzheimer's & Dementia 13 (1), 45-58, 2017 | 283 | 2017 |
Exercise benefits on Alzheimer’s disease: State-of-the-science PL Valenzuela, A Castillo-García, JS Morales, P de la Villa, H Hampel, ... Ageing research reviews 62, 101108, 2020 | 280 | 2020 |
A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ... Frontiers in immunology 11, 456, 2020 | 271 | 2020 |
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 261 | 2018 |
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research SE O'Bryant, V Gupta, K Henriksen, M Edwards, A Jeromin, S Lista, ... Alzheimer's & Dementia 11 (5), 549-560, 2015 | 258 | 2015 |
Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease SJ Teipel, M Grothe, S Lista, N Toschi, FG Garaci, H Hampel Medical Clinics 97 (3), 399-424, 2013 | 233 | 2013 |
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 213 | 2018 |
EEG evidence of compensatory mechanisms in preclinical Alzheimer’s disease S Gaubert, F Raimondo, M Houot, MC Corsi, L Naccache, J Diego Sitt, ... Brain 142 (7), 2096-2112, 2019 | 192 | 2019 |
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia T Leyhe, CF Reynolds III, T Melcher, C Linnemann, S Klöppel, K Blennow, ... Alzheimer's & dementia 13 (1), 59-71, 2017 | 184 | 2017 |
Development of biomarkers to chart all Alzheimer’s disease stages: the royal road to cutting the therapeutic Gordian Knot H Hampel, S Lista, ZS Khachaturian Alzheimer's & dementia 8 (4), 312-336, 2012 | 159 | 2012 |
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 154 | 2019 |
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020 H Hampel, S Lista, SJ Teipel, F Garaci, R Nisticò, K Blennow, ... Biochemical pharmacology 88 (4), 426-449, 2014 | 150 | 2014 |
Blood and plasma-based proteomic biomarker research in Alzheimer's disease S Lista, F Faltraco, D Prvulovic, H Hampel Progress in neurobiology 101, 1-17, 2013 | 150 | 2013 |
Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018 | 148 | 2018 |
CSF biomarkers for the differential diagnosis of Alzheimer's disease: a large-scale international multicenter study M Ewers, N Mattsson, L Minthon, JL Molinuevo, A Antonell, J Popp, ... Alzheimer's & Dementia 11 (11), 1306-1315, 2015 | 143 | 2015 |
Biomarkers in sporadic and familial Alzheimer’s disease S Lista, SE O’Bryant, K Blennow, B Dubois, J Hugon, H Zetterberg, ... Journal of Alzheimer's Disease 47 (2), 291-317, 2015 | 137 | 2015 |